drugset / Trial / NCT07526194
A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated
RandomizedSequentialSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 in healthy male trial participants.
Timeline
- Start
- 2026-04-22
- Primary completion
- 2026-10-02
- Completion
- 2026-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3821001 | Unknown | — | — |
Indications
No indication recorded.